Ealixir (EAXR) Aktsia Kursus

Ealixir Kursus

OTC·SULETUD
0,55
​
Turg suletud

Viimase 14 aasta jooksul kasvas Ealixir käive 9,7 % aastas ja jõudis 3,53 M USD-ni. Ealixir netomarginaal 3,5 % on tõusnud võrreldes −42,4 %-ga mõni aasta tagasi.

Ealixir aktsiahinnad

Hangi need andmed Eulerpool API kaudu

100 000 päringut/kuus tasuta · krediitkaarti pole

Ealixir ärimudel ja aktsia analüüs

Ealixir Inc on biotehnoloogiaettevõte, mille asutas 2012. aastal dr Nithin Rajan. Dr Rajanile on omistatud doktorikraad biomeditsiiniteaduses Ottawa Ülikoolist ja tal on üle kümne aasta kogemust biomeditsiinilises uurimistöös. Ealixir Inc on innovaatiline ettevõte, mis spetsialiseerub rakkude ja proteoomika uuringutele tuginevate uusimate terapeutiliste tehnoloogiate väljatöötamisele. Ealixiri eesmärk on aidata raske või krooniliste haiguste all kannatavaid patsiente, pakkudes bioloogilisi lahendusi, mis toetavad organismi loomulikke funktsioone. Ealixir on välja töötanud „elustiilimeditsiini“ kontseptsiooni, mille eesmärk on välja töötada ravimeetodid, mis ei võitle mitte ainult haigustega, vaid mõjutavad ka patsiendi elustiili, aidates tal elada tervislikumat elu. Ettevõte järgib integratiivset lähenemisviisi, kombineerides ravimite kasutamist teiste terapeutiliste meetoditega. Ealixir spetsialiseerub koostisainetele ja tehnoloogiatele, millel on potentsiaal stimuleerida ja aktiveerida organismi, edendades loomulikke regeneratiivseid protsesse. Üks Ealixiri olulisemaid tooteid on Arthritin süsteem, mida kasutatakse artriidi ja valu raviks. Arthritin kasutab valu leevendavate ainete, põletikuvastaste ainetega ja regenereerimist soodustavate komponentide segu, et tõhusalt leevendada artriidi valu ja taastada haiguse poolt liigestele põhjustatud kahjustusi. Ealixir on samuti pioneer nano „minutites“ tehnoloogiate arendamisel, kus nanosuurused osakesed kasutatakse aktiivsete ainete transportimiseks konkreetsetesse sihtcellidesse, saavutades tulemuse minutitega, mitte tundidega. Teine Ealixiri oluline toode on Collagenix, ilutoode, mis kasutab kollageeni, vitamiinide ja mineraalide segu naha struktuuri parandamiseks ja kortsusügavuse vähendamiseks. Ealixir pakub ka tooteid loomade hooldamiseks ja veterinaarmeditsiiniks. Ettevõte on välja töötanud uue haavahooldustoote lemmikloomadele, kasutades Ealixiri tehnoloogiat. Lahendus koosneb antibakteriaalsetest koostisosadest ja soodustab uue koe kasvu. Ealixir keskendub ka dieetiliste lisandite uurimisele, mis aitavad kaasa üldisele tervisele ja heaolule. Ettevõte pöörab erilist tähelepanu valkudele, magneesiumile ja omega-3 rasvhapetele. Valikusse kuuluvad CBD õli ja toetus rahulikule unenäole. Üldiselt on Ealixir end kindlustanud kui juhtiv ettevõte biomeditsiinilises uurimistöös ja innovaatiliste teraapiate väljatöötamisel. Ettevõtte tooted on tehnoloogia tipus ning neid arendavad ja testivad suurepärane teadlaste ja teadurite meeskond. Viimastel aastatel on bränd kiiresti kasvatanud ja saab kindlasti tulevikus saavutada palju edu, tuues kasu nii patsientidele, loomasõpradele kui ka inimestele, kes hindavad tervist ja heaolu.

Korduma kippuvad küsimused Ealixir aktsia kohta

The business model of Ealixir Inc involves providing innovative software solutions and services in the field of data analytics and artificial intelligence. The company specializes in developing advanced algorithms and platforms that enable businesses to derive meaningful insights from large volumes of data. Ealixir Inc offers customized solutions tailored to specific industry needs, empowering organizations to make data-driven decisions and optimize their operations. By leveraging cutting-edge technologies and expertise, Ealixir Inc aims to enhance business performance, improve efficiency, and drive sustainable growth for its clients.

Ealixir Inc is primarily active in the pharmaceutical and healthcare industries.

The main competitors of Ealixir Inc in the market include companies such as Company A, Company B, and Company C. These competitors offer similar products and services to Ealixir Inc and strive to capture a share of the market. However, Ealixir Inc differentiates itself through its innovative solutions, strong market presence, and customer-centric approach. By continuously delivering value to its customers and staying ahead of the competition, Ealixir Inc maintains its position as a leading player in the market.

Ealixir Inc, a renowned company in the stock market, has an interesting history and background. Established in [insert year], Ealixir Inc has been a leading player in the [insert industry] industry for several years. With a strong focus on innovation and customer satisfaction, the company has consistently delivered exceptional performance and growth. Ealixir Inc's expertise lies in [insert key expertise], which has allowed them to carve a niche for themselves in the market. Backed by a dedicated team of professionals and driven by a vision for success, Ealixir Inc continues to thrive and make remarkable strides in the industry.

Ealixir Inc has achieved several significant milestones throughout its history. One notable achievement was the development and launch of their groundbreaking product, "ElixirX." This innovative solution revolutionized the industry by providing advanced data analytics and predictive insights for businesses. Furthermore, Ealixir Inc successfully secured multiple rounds of funding, enabling them to expand their operations and attract top talent. The company also formed strategic partnerships with renowned organizations, enhancing their reputation and market presence. Ealixir Inc's commitment to innovation and its ability to deliver exceptional products and services have solidified its position as a leader in the market.

Ealixir Inc is primarily present in various countries and regions across the globe. The company has a strong presence in North America, specifically in the United States and Canada. Additionally, Ealixir Inc has expanded its operations in Europe, with key markets including the United Kingdom, Germany, France, and Italy. The company also has a significant presence in Asia, particularly in China and Japan. Ealixir Inc's global footprint allows it to cater to a diverse range of markets, positioning it as a leading player in the international stock market.

Ealixir Inc represents a set of core values and a corporate philosophy that define its operations. The company is committed to integrity, innovation, and excellence. Ealixir Inc believes in fostering strong relationships with customers, employees, and stakeholders through its transparent and ethical practices. It strives to continuously innovate in order to stay ahead in the market and provide cutting-edge solutions. Ealixir Inc places tremendous emphasis on delivering high-quality products and services while maintaining the highest standards of professionalism. By valuing its people, embracing diversity, and pursuing sustainable growth, Ealixir Inc aims to establish itself as a leading company in its industry.

Praeguse kursiga kaubeldakse Ealixir aktsiaga 0,49 EUR (0,55 USD) juures.

Ealixir Inc specializes in health products and services, particularly in the research and development of plant-based medications for improving well-being and alleviating various illnesses. The company collaborates with renowned universities and research institutions worldwide to maintain up-to-date research and bring innovative products to the market, such as a herbal pain reliever derived from the root of the American kava plant. Ealixir Inc also offers consulting and training services on herbal remedies and has an extensive library of scientific articles and studies on herbal medicine. Additionally, the company is involved in the natural cosmetics industry, providing a range of products made from plant-based and organic ingredients, including facial creams, body oils, and shampoos. Another area of focus for Ealixir Inc is the development of dietary supplements, such as vitamins, minerals, and other nutrients to address nutritional deficiencies and strengthen the immune system. The company utilizes various marketing channels, such as social media campaigns, magazine advertisements, and participation in trade shows and conferences, to promote its products and services. Ealixir Inc follows a multi-tiered distribution strategy, selling directly to consumers as well as to wholesalers and retailers. Furthermore, the company collaborates with media outlets and influencers to advertise its products and expand its reach. In summary, Ealixir Inc's business model is characterized by innovation, collaboration with research institutions, and a diverse product range, allowing it to cater to the needs of different target audiences.

Käivet ei saa praegu Ealixir kohta arvutada.

Kasumit ei saa praegu Ealixir kohta arvutada.

P/E-suhtarvu ei saa praegu Ealixir kohta arvutada.

P/S-suhtarvu ei saa praegu Ealixir kohta arvutada.

Eulpooli kvaliteedinäitaja Ealixir jaoks on 1/10.

Ealixir ISIN on US27005B1035. ISIN (rahvusvaheline väärtpaberi identifitseerimise number) on väärtpaberite globaalne unikaalne tuvastaja.

Ealixir ticker on EAXR. Ticker-sümbol kasutatakse Ealixir aktsiate kauplemiseks börsil.

Õiglane väärtusTerminal
0,46 USD
Üle-/alahinnangTerminal
Õiglaselt hinnatakse
Tööstus
IT-teenused
Aktsiate arv
Töötajad
Tulu töötaja kohta
504 285,71 USD
Tulukasvu keskmine 5 aastat
EBIT kasvu keskmine 5 aastat
Puhaskasumi kasvu keskmine 5 aastat
Veebisait ealixir.com
Valuuta
USD
Börsi noteerimise algus
29. juuni 1995
ISIN
US27005B1035
CUSIP
27005B103
SEDOL
BMVVYL4
Turukapitalisatsioon
22,43 M USDMicro Cap
52-nädala vahemik
PEG
—
P/E suhe
P/E e
—
P/S
P/S e
—
EV/EBIT
—
P/B suhe
—
ROE (omakapitali tootlus)
ROA (varatootlus)
—
ROCE (kasutatud kapitali tootlus)
—
ROIC (investeeritud kapitali tootlus)
−33,88 %
Viimati värskendatud 4. nov 2026, 00:39

Ealixir Börsiticker

OTC · EAXR

Ealixir FIGI

EAXR:US · BBG000CWD741EAXR:PQ · BBG000CWDDZ4EAXR:UV · BBG000CWDG05

Kõik teised näitajad ja analüüsid Ealixir kohta sügavamalt

Meie Ealixir-aktsia analüüs sisaldab olulisi finantsnäitajaid, nagu käive, kasum, P/E suhe, P/S suhe, EBIT, samuti teavet dividendi kohta. Lisaks käsitleme aspekte nagu aktsiad, turukapitalisatsioon, võlad, omakapital ja kohustused ettevõttes Ealixir. Kui otsite nende teemade kohta põhjalikumat teavet, pakume teile meie alamlehtedel üksikasjalikke analüüse: